A systematic review on zinc for the prevention and treatment of age-related macular degeneration

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 6, 2013, Pages 3985-3998

  Vishwanathan, Rohini ^a   Chung, Mei ^b   Johnson, Elizabeth J ^a  

^a TUFTS UNIVERSITY   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Age related macular degeneration; Systematic review; Zinc

Indexed keywords

PLACEBO; UNCLASSIFIED DRUG; ZINC ION; ZINC MONOCYSTEINE; ZINC OXIDE; ZINC SULFATE;

COLOR DISCRIMINATION; CONTRAST SENSITIVITY; DIETARY INTAKE; DISEASE COURSE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; INCIDENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA LUTEA; REVIEW; SUBRETINAL NEOVASCULARIZATION; SYSTEMATIC REVIEW; UROGENITAL TRACT DISEASE; VISUAL ACUITY;

AGE-RELATED MACULAR DEGENERATION; SYSTEMATIC REVIEW; ZINC;

AGED; CASE-CONTROL STUDIES; DATABASES, FACTUAL; DIET; DIETARY SUPPLEMENTS; DISEASE PROGRESSION; FEMALE; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VISUAL ACUITY; ZINC COMPOUNDS;

EID: 84878982146     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-11552     Document Type: Review

References (34)

1. Klein R, Klein BE, Jensen SC, Mares-Perlman JA, Cruickshanks KJ, Palta M. Age-related maculopathy in a multiracial United States population: the National Health and Nutrition Examination Survey III. Ophthalmology. 1999;106:1056-1065.
2. Prevalence of Blindness Data Tables (NEI Statistics and Data). National Eye Institute, National Institutes of Health. 2004. Available at: http://www.nei.nih.gov/eyedata/. Accessed June 7, 2012.
3. Lim LS, Mitchell P, Seddon JM, Holz FG, Wong TY. Age-related macular degeneration. Lancet. 2012;379:1728-1738.
4. Snodderly DM. Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins. Am J Clin Nutr. 1995;62:1448S-1461S.
5. O'Dell BL. Role of zinc in plasma membrane function. J Nutr. 2000;130:1432S-1436S.
6. Food and Nutrition Board. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC: National Academy Press; 2001.
7. Prasad AS. Zinc deficiency in humans: a neglected problem. J Am Coll Nutr. 1998;17:542-543.
8. Grahn BH, Paterson PG, Gottschall-Pass KT, Zhang Z. Zinc and the eye. J Am Coll Nutr. 2001;20:106-118.
9. Cousins RJ. Zinc. In: Bowen BA, Russell, RM, ed. Present Knowledge in Nutrition. 9th ed. Vol. 1. Washington, DC: ILSI Press; 2006;445-457.
10. Higgins JPT, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
11. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
12. Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2011. Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed May 17, 2013.
13. VandenLangenberg GM, Mares-Perlman JA, Klein R, Klein BEK, Brady WE, Palta M. Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculop-athy in the Beaver Dam Eye Study. Am J Epidemiol. 1998;148: 204-214.
14. Cho E, Stampfer MJ, Seddon JM, et al. Prospective study of zinc intake and the risk of age-related macular degeneration. Ann Epidemiol. 2001;11:328-336.
15. van Leeuwen R, Boekhoorn S, Vingerling JR, et al. Dietary intake of antioxidants and risk of age-related macular degeneration. JAMA. 2005;294:3101-3107.
16. Tan JSL, Wang JJ, Flood V, Rochtchina E, Smith W, Mitchell P. Dietary antioxidants and the long-term incidence of agerelated macular degeneration: the Blue Mountains Eye Study. Ophthalmology. 2008;115:334-341.
17. Mares-Perlman JA, Klein R, Klein BEK, et al. Association of zinc and antioxidant nutrients with age-related maculopathy. Arch Ophthalmol. 1996;114:991-997.
18. Morris MS, Jacques PF, Chylack LT, et al. Intake of zinc and antioxidant micronutrients and early age-related maculopathy lesions. Ophthalmic Epidemiol. 2007;14:288-298.
19. Newsome DA, Swartz M, Leone NC, Elston RC, Miller E. Oral zinc in macular degeneration. Arch Ophthalmol. 1988;106: 192-198.
20. Stur M, Tittl M, Reitner A, Meisinger V. Oral zinc and the second eye in age-related macular degeneration. Invest Ophthalmol Vis Sci. 1996;37:1225-1235.
21. Age-related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta-carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001;119:1417-1436.
22. Newsome DA, Randomized, A. Prospective, placebo-controlled clinical trial of a novel zinc-monocysteine compound in age-related macular degeneration. Curr Eye Res. 2008;33: 591-598.
23. Lindblad A, Lloyd P, Clemons T, et al. Change in area of geographic atrophy in the Age-Related Eye Disease Study: AREDS report number 26. Arch Ophthalmol. 2009;127:1168.
24. Gregori NZ, Feuer W, Rosenfeld PJ. Novel method for analyzing Snellen visual acuity measurements. Retina. 2010; 30:1046-1050.
25. Chong EWT, Wong TY, Kreis AJ, Simpson JA, Guymer RH. Dietary antioxidants and primary prevention of age related macular degeneration: systematic review and meta-analysis. BMJ. 2007;335:755.
26. Evans J. Antioxidant supplements to prevent or slow down the progression of AMD: a systematic review and meta-analysis. Eye (Lond). 2008;22:751-760.
27. Grover S, Fishman GA, Gilbert LD, Anderson RJ. Reproducibility of visual acuity measurements in patients with retinitis pigmentosa. Retina. 1997;17:33-37.
28. Hudson HL, Lane SS, Heier JS, et al. Implantable miniature telescope for the treatment of visual acuity loss resulting from end-stage age-related macular degeneration: 1-year results. Ophthalmology. 2006;113:1987-2001.
29. Age-Related Eye Disease Study Research Group. The Age- Related Eye Disease Study: a clinical trial of zinc and antioxidants-Age-Related Eye Disease Study Report No. 2. J Nutr. 2000;130:1516S-1519S.
30. Stipanuk M. Homocysteine, Cysteine, and Taurine. Baltimore, MD: Williams & Wilkins; 1999.
31. Food and Nutrition Board, Institute of Medicine, National Academies. Dietary reference intakes (DRIs): recommended dietary allowances and adequate intakes, vitamins. Available at: http://iom.edu/Activities/Nutrition/SummaryDRIs/~/media/ Files/Activity%20Files/Nutrition/DRIs/RDA%20and%20AIs_Vitamin%20and%20Elements.pdf. Accessed December 12, 2012.
32. Dickersin K, Rennie D. Registering clinical trials. JAMA. 2003; 290:516-523.
33. Siepmann M, Spank S, Kluge A, Schappach A, Kirch W. The pharmacokinetics of zinc from zinc gluconate: a comparison with zinc oxide in healthy men. Int J Clin Pharmacol Ther. 2005;43:562-565.
34. Age-Related Eye Disease Study. AREDS 2. Available at: www.areds2.org. Accessed June 10, 2011.